Using Telemedicine to Treat Opioid Use DisorderTHURSDAY, OCTOBER 11, 2018
To combat limited access to medication-assisted treatment (MAT) of opioid use disorder (OUD) in rural areas, the Drug Enforcement Administration (DEA) and U.S. Department of Health and Human Services (HHS) has developed Telemedicine and Prescribing Buprenorphine for the Treatment of Opioid Use Disorder to help clarify how clinicians can use telemedicine as a tool to expand buprenorphine-based MAT for OUD treatment under current DEA regulations. This guidance includes a clinical case example.
Recent News & Events
Enhancing Your Safety Culture
99999989When you think of organizational culture, what comes to mind? Perhaps you think of a just culture or a learning culture. But, have you considered a patient safety culture? We know...
Follow-Up System Failures: Closing the Loop on the Diagnostic Process Part 1
99999989Follow-up system failures contribute to almost half of all diagnostic error malpractice claims. Even when appropriate clinical steps are taken to lead to a correct diagnosis, we still see diagnostic error due to failures in follow-up systems...